Keyphrases
Acute Myeloid Leukemia
100%
Overall Survival
100%
Cytarabine
100%
Induction Treatment
100%
AML12
100%
Consolidation Treatment
100%
Complete Remission
66%
Transplantation
66%
Daunorubicin
66%
Thioguanine
50%
Chemotherapy
33%
Etoposide
33%
Relapse Risk
33%
Mitoxantrone
33%
Young Patients
16%
Conventional Chemotherapy
16%
All-trans Retinoic Acid
16%
Remission Rate
16%
Older Patients
16%
New Agents
16%
Myelosuppression
16%
Clinical High Risk
16%
Chemotherapy Schedule
16%
Relapse-free Survival
16%
Leukemia Risk
16%
High-risk Myelodysplastic Syndrome
16%
Intermediate-risk Group
16%
Pharmacology, Toxicology and Pharmaceutical Science
Overall Survival
100%
Acute Myeloid Leukemia
100%
Cytarabine
100%
Remission
83%
Chemotherapy
66%
Daunorubicin
66%
Tioguanine
50%
Mitoxantrone
33%
Etoposide
33%
Retinoic Acid
16%
Bone Marrow Suppression
16%
Recurrence Free Survival
16%
Myelodysplastic Syndrome
16%
Medicine and Dentistry
Acute Myeloid Leukemia
100%
Overall Survival
100%
Cytarabine
100%
Liposomal Daunorubicin
66%
Tioguanine
50%
Mitoxantrone
33%
Etoposide
33%
Arm
16%
Spontaneous Remission
16%
Bone Marrow Suppression
16%
Tretinoin
16%
Recurrence Free Survival
16%
Myelodysplastic Syndrome
16%
Intermediate Risk Population
16%
Neuroscience
Myeloid
100%
Cytarabine
100%
Daunorubicin
66%
Tioguanine
50%
Mitoxantrone
33%
Etoposide
33%
Tretinoin
16%